Prognostic Significance of Pretreatment Apolipoprotein A-I as a Noninvasive Biomarker in Cancer Survivors: A Meta-Analysis.
Conclusions. Low ApoA-I level might be an unfavorable prognostic factor in multiple malignancies, and serum ApoA-I could serve as a noninvasive marker to predict cancer prognosis.
PMID: 30510601 [PubMed - in process]
Source: Disease Markers - Category: Laboratory Medicine Tags: Dis Markers Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | China Health | Colorectal Cancer | Databases & Libraries | Hepatocellular Carcinoma | Laboratory Medicine | Liver Cancer | Nasopharyngeal Cancer | Science | Study